US Stock MarketDetailed Quotes

TNGX Tango Therapeutics

Watchlist
  • 1.825
  • -0.075-3.95%
Trading Mar 4 11:01 ET
197.30MMarket Cap-1.53P/E (TTM)

Tango Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
15.17%42.07M
-24.19%4.12M
8.15%11.61M
36.15%19.88M
12.23%6.47M
46.93%36.53M
-15.29%5.43M
55.09%10.73M
152.95%14.6M
0.14%5.77M
Operating revenue
15.17%42.07M
-24.19%4.12M
8.15%11.61M
36.15%19.88M
12.23%6.47M
46.93%36.53M
-15.29%5.43M
55.09%10.73M
152.95%14.6M
0.14%5.77M
Cost of revenue
Gross profit
Operating expense
24.53%187.66M
11.33%45.03M
22.35%44.49M
30.60%49.43M
35.15%48.73M
10.87%150.7M
9.37%40.44M
-1.32%36.36M
22.19%37.85M
15.79%36.05M
Selling and administrative expenses
23.22%43.75M
21.80%11.09M
21.86%11.22M
17.43%10.77M
33.05%10.66M
18.24%35.5M
15.44%9.11M
13.71%9.21M
26.85%9.17M
17.72%8.01M
-General and administrative expense
23.22%43.75M
21.80%11.09M
21.86%11.22M
17.43%10.77M
33.05%10.66M
18.24%35.5M
15.44%9.11M
13.71%9.21M
26.85%9.17M
17.72%8.01M
Research and development costs
24.93%143.92M
8.29%33.94M
22.52%33.26M
34.82%38.65M
35.76%38.07M
8.77%115.2M
7.73%31.34M
-5.55%27.15M
20.77%28.67M
15.24%28.04M
Operating profit
-27.52%-145.6M
-16.84%-40.91M
-28.30%-32.88M
-27.12%-29.55M
-39.52%-42.26M
-2.79%-114.17M
-14.55%-35.01M
14.36%-25.63M
7.76%-23.25M
-19.33%-30.29M
Net non-operating interest income expense
19.20%7.89M
-18.92%1.81M
-3.37%1.81M
42.83%2.07M
107.07%2.2M
354.60%6.62M
278.34%2.24M
434.86%1.87M
388.22%1.45M
386.70%1.06M
Non-operating interest income
19.20%7.89M
-18.92%1.81M
-3.37%1.81M
42.83%2.07M
107.07%2.2M
354.60%6.62M
278.34%2.24M
434.86%1.87M
388.22%1.45M
386.70%1.06M
Other net income (expense)
28.05%7.61M
-28.38%1.48M
29.19%1.96M
73.33%2M
79.46%2.18M
298.12%5.94M
113.13%2.06M
189.48%1.51M
2,202.00%1.15M
2,689.36%1.22M
Other non- operating income (expenses)
28.05%7.61M
-28.38%1.48M
29.19%1.96M
73.33%2M
79.46%2.18M
298.12%5.94M
113.13%2.06M
189.48%1.51M
2,202.00%1.15M
2,689.36%1.22M
Income before tax
-28.03%-130.09M
-22.48%-37.62M
-30.90%-29.11M
-23.44%-25.49M
-35.23%-37.87M
6.02%-101.61M
-5.88%-30.72M
23.44%-22.24M
16.93%-20.65M
-11.11%-28.01M
Income tax
55.22%208K
4.26%49K
134.78%54K
1.56%65K
40K
148.15%134K
-7.84%47K
23K
2,033.33%64K
0
Net income
-28.07%-130.3M
-22.45%-37.67M
-31.01%-29.17M
-23.38%-25.55M
-35.37%-37.91M
5.95%-101.74M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
Net income continuous Operations
-28.07%-130.3M
-22.45%-37.67M
-31.01%-29.17M
-23.38%-25.55M
-35.37%-37.91M
5.95%-101.74M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
Minority interest income
Net income attributable to the parent company
-28.07%-130.3M
-22.45%-37.67M
-31.01%-29.17M
-23.38%-25.55M
-35.37%-37.91M
5.95%-101.74M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-28.07%-130.3M
-22.45%-37.67M
-31.01%-29.17M
-23.38%-25.55M
-35.37%-37.91M
5.95%-101.74M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
Basic earnings per share
-10.19%-1.19
-16.67%-0.35
-17.39%-0.27
-4.35%-0.24
-9.37%-0.35
12.20%-1.08
9.09%-0.3
30.30%-0.23
17.86%-0.23
-10.34%-0.32
Diluted earnings per share
-10.19%-1.19
-16.67%-0.35
-17.39%-0.27
-4.35%-0.24
-9.37%-0.35
12.20%-1.08
9.09%-0.3
30.30%-0.23
17.86%-0.23
-10.34%-0.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 15.17%42.07M-24.19%4.12M8.15%11.61M36.15%19.88M12.23%6.47M46.93%36.53M-15.29%5.43M55.09%10.73M152.95%14.6M0.14%5.77M
Operating revenue 15.17%42.07M-24.19%4.12M8.15%11.61M36.15%19.88M12.23%6.47M46.93%36.53M-15.29%5.43M55.09%10.73M152.95%14.6M0.14%5.77M
Cost of revenue
Gross profit
Operating expense 24.53%187.66M11.33%45.03M22.35%44.49M30.60%49.43M35.15%48.73M10.87%150.7M9.37%40.44M-1.32%36.36M22.19%37.85M15.79%36.05M
Selling and administrative expenses 23.22%43.75M21.80%11.09M21.86%11.22M17.43%10.77M33.05%10.66M18.24%35.5M15.44%9.11M13.71%9.21M26.85%9.17M17.72%8.01M
-General and administrative expense 23.22%43.75M21.80%11.09M21.86%11.22M17.43%10.77M33.05%10.66M18.24%35.5M15.44%9.11M13.71%9.21M26.85%9.17M17.72%8.01M
Research and development costs 24.93%143.92M8.29%33.94M22.52%33.26M34.82%38.65M35.76%38.07M8.77%115.2M7.73%31.34M-5.55%27.15M20.77%28.67M15.24%28.04M
Operating profit -27.52%-145.6M-16.84%-40.91M-28.30%-32.88M-27.12%-29.55M-39.52%-42.26M-2.79%-114.17M-14.55%-35.01M14.36%-25.63M7.76%-23.25M-19.33%-30.29M
Net non-operating interest income expense 19.20%7.89M-18.92%1.81M-3.37%1.81M42.83%2.07M107.07%2.2M354.60%6.62M278.34%2.24M434.86%1.87M388.22%1.45M386.70%1.06M
Non-operating interest income 19.20%7.89M-18.92%1.81M-3.37%1.81M42.83%2.07M107.07%2.2M354.60%6.62M278.34%2.24M434.86%1.87M388.22%1.45M386.70%1.06M
Other net income (expense) 28.05%7.61M-28.38%1.48M29.19%1.96M73.33%2M79.46%2.18M298.12%5.94M113.13%2.06M189.48%1.51M2,202.00%1.15M2,689.36%1.22M
Other non- operating income (expenses) 28.05%7.61M-28.38%1.48M29.19%1.96M73.33%2M79.46%2.18M298.12%5.94M113.13%2.06M189.48%1.51M2,202.00%1.15M2,689.36%1.22M
Income before tax -28.03%-130.09M-22.48%-37.62M-30.90%-29.11M-23.44%-25.49M-35.23%-37.87M6.02%-101.61M-5.88%-30.72M23.44%-22.24M16.93%-20.65M-11.11%-28.01M
Income tax 55.22%208K4.26%49K134.78%54K1.56%65K40K148.15%134K-7.84%47K23K2,033.33%64K0
Net income -28.07%-130.3M-22.45%-37.67M-31.01%-29.17M-23.38%-25.55M-35.37%-37.91M5.95%-101.74M-5.86%-30.76M23.36%-22.26M16.69%-20.71M-11.11%-28.01M
Net income continuous Operations -28.07%-130.3M-22.45%-37.67M-31.01%-29.17M-23.38%-25.55M-35.37%-37.91M5.95%-101.74M-5.86%-30.76M23.36%-22.26M16.69%-20.71M-11.11%-28.01M
Minority interest income
Net income attributable to the parent company -28.07%-130.3M-22.45%-37.67M-31.01%-29.17M-23.38%-25.55M-35.37%-37.91M5.95%-101.74M-5.86%-30.76M23.36%-22.26M16.69%-20.71M-11.11%-28.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -28.07%-130.3M-22.45%-37.67M-31.01%-29.17M-23.38%-25.55M-35.37%-37.91M5.95%-101.74M-5.86%-30.76M23.36%-22.26M16.69%-20.71M-11.11%-28.01M
Basic earnings per share -10.19%-1.19-16.67%-0.35-17.39%-0.27-4.35%-0.24-9.37%-0.3512.20%-1.089.09%-0.330.30%-0.2317.86%-0.23-10.34%-0.32
Diluted earnings per share -10.19%-1.19-16.67%-0.35-17.39%-0.27-4.35%-0.24-9.37%-0.3512.20%-1.089.09%-0.330.30%-0.2317.86%-0.23-10.34%-0.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More